One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Cell Surface Markers Detection Market

[ 英語タイトル ] Cell Surface Markers Detection Market - Growth, Trends, and Forecasts (2020 - 2025)

Product Code : MDHC0083618
Survey : Mordor Intelligence
Publish On : November, 2020
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Abbott Laboratories
- Beckman Coulter, Inc
- Becton, Dickinson and Company
- Bio Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd
- Luminex Corporation
- Nihon Kohden Corporation
- Qiagen NV
- Siemens Healthineers
- Thermo Fisher Scientific, Inc.

[Report Description]

The global cell surface markers detection market is expected to witness a CAGR of 8.2%. Prominent factors that are driving the market growth include the increased use in diagnostics, an increasing demand for precision medicine, and technological advances related to increased throughput and automation.

Cell surface markers are also known as cell surface antigens, and serve as monograms to help identify and classify cells. The proteins expressed on the surface of cells often conveniently serve as markers of specific cell types. Even in the different types of cells there are specific combinations of markers or antigens. This molecule identification helps in disease diagnoses, to find the direct treatment for the disease, drug discovery, and many more. Cell markers also assists in the determination of cell type expression of specific receptors, vital for biological response. It can be useful even in personalized medicine, in which it can help the physician decide the most effective therapy to be used for the patient, by analyzing and understanding the cells isolated from patients.

Key Market Trends

Disease Diagnosis and Identification Segment is Expected to Grow at Fastest Rate

Fueled by recent technological advances and increasing demand for more accurate diagnostics the disease diagnosis and identification segment is expected to register a high CAGR. In the disease diagnosis and identification field, surface marker detection techniques are finding their increased application in screening of cancer biomarkers. This is primararily due to the high senstivity and early diagnostic capabilities of cell surface marker detection techniques.

Furthermore, the highly damaging effects of currently available tumor-detection methods, such as PCR, and immunohistochemistry limits their usages in novel fields, such as tissue implantation after screening. These issues are leading to increased intrest in the development of less destructive cancer screening methods, which, in turn, is driving market expansion.

United States Domainates the Market and is Expected To Retain its Market Share During the Forecast Period

The United States currently dominates the market for cell surface marker detection and is expected to continue its stronghold for a few more years. Rapidly growing applications in disease diagnostics, the presence of well-established research institutions, and the biotech industry are primary reasons behind the large market size. Moreover, high healthcare expenditure, a high technological adaptation rate, and increasing focus on precise and timely diagnostics are driving the market growth in the United States.

Competitive Landscape

The global cell surface market detection market is dominated by some key global players, especially in the instrument front. Several biotech startups, however, are active in the reagent, consumables, and other niche fields. There is an ongoing trend of further consolidationm with the acquisition of new technology being a major focus. There are also some instances of acquisition of product lines and bands between key market participants.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Use in Diagnostics
4.2.2 Technological Advances Related to Increased Throughput and Automation
4.2.3 Increasing Demand for Precision Medicine
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.3.2 Complexity of Techniques
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 Product
5.1.1 Flow Cytometry
5.1.2 Hematology Analyzers
5.1.3 Cell Imaging Systems
5.1.4 Reagents and Kits
5.2 Application
5.2.1 Disease Diagnosis and Identification
5.2.2 Research and Drug Discovery
5.2.3 Other Applications
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Beckman Coulter, Inc
6.1.3 Becton, Dickinson and Company
6.1.4 Bio Rad Laboratories Inc.
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Luminex Corporation
6.1.7 Nihon Kohden Corporation
6.1.8 Qiagen NV
6.1.9 Siemens Healthineers
6.1.10 Thermo Fisher Scientific, Inc.




Recommended reports